[go: up one dir, main page]

WO1987004930A1 - Sulphamic science - Google Patents

Sulphamic science Download PDF

Info

Publication number
WO1987004930A1
WO1987004930A1 PCT/AU1987/000050 AU8700050W WO8704930A1 WO 1987004930 A1 WO1987004930 A1 WO 1987004930A1 AU 8700050 W AU8700050 W AU 8700050W WO 8704930 A1 WO8704930 A1 WO 8704930A1
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
infection
solution
sulphamic
sloughing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/AU1987/000050
Other languages
French (fr)
Inventor
Donald Stephen Clarke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO1987004930A1 publication Critical patent/WO1987004930A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof

Definitions

  • This treatment may be an alternative to Fluoridation in Dental Health.
  • the active ingredient used in all these treatments is H.N.S.O.H. 2 3.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

An alternative treatment to medication for certain infections. By causing a mild chemical scald of the outer receptive layer of the membrane. The once-off removal of the surface tissue clears off the host material before infection takes place. Desloughing the base removes the medium that pathogens and rinovirus attach to initiate infection. This concept of localised treatment of known points of entry as distinct to general medications. The desloughing agent or active ingredient is H2NSOH3.

Description

SULPHAMIC SCIENCE
1.
1. The advantages of these treatments over orthodox medicines is no ingesting of oral drugs.
2. There is no introduced antigens as in vacines.
3. This treatment may be an alternative to Fluoridation in Dental Health.
4 This programne is a departure from accepted practice but in the limited testing so far has been giving encouraging results.
5. The active ingredient used in all these treatments is H.N.S.O.H. 2 3.
6. The one-off de-sloughing of the target zone or point of entry is a new concept.
7. In the limited tests I have done all have been entirely painless except Claim-No.6.
8. By undertaking the treatment before infection sets in ones body does not have to contend with the illness or the medication. 9 . -WARNING-Some Aut ho r i t i es . F . D . A . o f U . S . A . l i s t
H . N . S ... H . as a hazardous material. 2 3

Claims

CLAIM .1. THE Inventive Idea is in the field of Health Care and Preventive Medicine. To prevent the infection by removing the base or medium where pathogens first get established. By one-off desloughing of the well known point of entry before infection takes place
I have discovered that the chemical Sulphamic Acid. is a strong desloughing agent and has anti-bacterial properties.
DENTAL. HEALTH. By swabbing the gums with awater-based solution of Sulphamic Acid causes a light film to shed off. This film-The host of the organisms of
Streptococus Mutans. Removal of this film leaves adistinct high-water mark across the lower root-end of the teeth and reduces the build-up of plaque coating on the teeth. Length treatment is usually 8-10 days.
The process is totally painless. As this is a new concept I cannot compare it it with usual methods until more study has been undertaken. The active, ingredient in this preparation is
H.N.S.O.H. 2 3
Claim. 2.
The Inventive Idea is in the field of Health Care and Preventive Medicine .
To prevent the infection by removing the base or medium where pathogens first get established.
By one-off de-sloughing of the well known point of entry before infection takes place.
I have discovered that the chemical Sulphamic Acid is a strong desloughing agent and has anti-bacterial properties.
De-sloughing of the troat to reduce infection from Rhino-virus and Common Colds.
A light gargle once per day removes the material the rodent pathogens and Rhino-virus attach to to initiate
Throat infection. THIS treatment is localised to the area where infection begins.
This method does not use any ingested medicines. Length of treatment usually 8-10 days
The process is totally painless. As this is a new concept I cannot compare it with usual methods until more study has been undertaken.
The active ingredient in this preparation is
HNSOH
2 3.
Claim. 3.
The Inventive Idea is in the field of Health Care and Preventive Medicine.
Treatment of Herpes. inboth dormant and active stages.
I have discovered that the chemical Sulphamic Acid is a strong de-sloughant with anti-bacterial properties.
By swabbing an infected area ,or in the Latent form a location that has infected for a period of 8-10 days causes a protective layer to shed-off withno re-ocurrence in the tested time of 2years.
Length of treatment 8-10 days-one application per day with full strength water-based solution.
As this a new concept Icannot compare it with usual methods until more study has been undertaken.
The active ingredient in this preparation is
H.N.S.O.H. 2 3
CLAIM . 4 .
The Inventive Idea is in the field of Health Care, and Preventive Medicine. Pedicare or Relief of Foot Problems. A light application of Sulphamic solution over a period of 20 days or so will remove skin and abnormal growths from the feet including de-sloughing the between surfaces of the toes This removes the base of Tinea infection.
Painlessly removes corns and callouses from the feet to give general foot relief.
Length of treatment 20 days or so apply full strength solution.
The active ingredient in this preparation is.
H.N.S.O.H. 2 3
CLAIM.5.
The Inventive Idea is in the field of Health Care and Preventive Medicine.
Treatment of VARICOSE VEINS.
By swabbing of affected areas with sulphamic solution once every third day will isolate affected veins from circulatory system then shrink and re-absorb them back to almost normal size. It is most important to spread the treatment over several weeks to allow the circulation system to adjust. In the isolation period the treated veins turn black. After a while they shrink in size and return to normal color.
Length of treatment depending on severity up to 60 days.
Solution at full strength is swabbed on once every third day.
The active ingredient in this preparation is
H.N.S.O.H. 2 3
CLAIM. 6. Treatment of resistant facial infections.
I have discovered that Sulphamic solution is a strong de-sloughing agent and anti-bacterial medium . These two qualities combine well to make it a good base to use with other compounds like Salicilic Acid and
Benzoic Acid.
This combination is very effective on the resistant pus-forming infection around the base of the nose.
These infections tend to thicken the skin in the affected area as the pathogens colonise and spread. This solution will de-slough and remove the base of the infection and reduce scar tissue.
IT will inhibit abnormal cell development. Treatment time varies -continue daily application while infection lasts
Stop treatment should de-sloughing become painfull.
The active ingredient in this preparation is.
H.N.S.O.H. 2 3
CLAIM. 7. CONTROL OF DISEASE IN DAIRY CATTLE.
I have discovered Sulphamic solution may be used as a de-sloughing agent to remove skin lesions and Teat callous in the control and prevention of Mastitus, Pseudo-cowpox, Black-spot, and Bovine-Herpes. Used as an additive to normallOdine Teat-dip this solution gradually removes over a period of time the skin lesions that host the Staphycocus Aureus, Streptococus, and other Pathogens. Normally the skin lesions provide protection to the rodent pathogens isolating them from the effect of the Teat- Dipping Treatment.
REmoving this protection de-sloughing greatly increases the benifit of the treament.
The treatment isan ongoing process with a low rate added to regular Teat-dip Mix. 24 grams per Litre.
This strength solution lowers the PH. of the skin surface and improves healing.
The active ingredient in this preparation is
H.N.S.O.H. 2 3
PCT/AU1987/000050 1986-02-24 1987-02-23 Sulphamic science Ceased WO1987004930A1 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
AU474086 1986-02-24
AU474186 1986-02-24
AU473986 1986-02-24
AU473886 1986-02-24
AU474286 1986-02-24
AUPH4742 1986-02-24
AUPH4740 1986-02-24
AUPH4738 1986-02-24
AUPH4739 1986-02-24
AUPH4741 1986-02-24

Publications (1)

Publication Number Publication Date
WO1987004930A1 true WO1987004930A1 (en) 1987-08-27

Family

ID=27506529

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU1987/000050 Ceased WO1987004930A1 (en) 1986-02-24 1987-02-23 Sulphamic science

Country Status (1)

Country Link
WO (1) WO1987004930A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE835929C (en) * 1949-05-12 1952-04-07 August Kettenbach Means for removing tartar
AU534966A (en) * 1965-07-26 1967-11-16 Wyandotte Chemicals Corporation Detergent compositions
AU1336970A (en) * 1970-04-03 1971-10-07
GB2164851A (en) * 1984-10-01 1986-04-03 Auchincloss Thomas R Dry, water soluble biocidal compositions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE835929C (en) * 1949-05-12 1952-04-07 August Kettenbach Means for removing tartar
AU534966A (en) * 1965-07-26 1967-11-16 Wyandotte Chemicals Corporation Detergent compositions
AU3682768A (en) * 1967-05-04 1969-10-30 Wyandotte Chemicals Corporation Iodine disinfectant
AU1336970A (en) * 1970-04-03 1971-10-07
GB2164851A (en) * 1984-10-01 1986-04-03 Auchincloss Thomas R Dry, water soluble biocidal compositions

Similar Documents

Publication Publication Date Title
CA1166575A (en) Therapeutic dimethyl sulfoxide composition and methods of use
US6264927B1 (en) Topical solution and method for the treatment of nail fungus
US7198806B2 (en) Composition and method for treatment and prevention of pruritis
BG64522B1 (en) Device for the treatment of viral infectiuous diseases
EA018425B1 (en) Pharmaceutical, disinfectant or preservation extract of trigonella foenum-graecum, method for preparing and use thereof
Iraji et al. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran
EP1143966B1 (en) Preparation for warts
JP2005508980A (en) Stomatitis treatment with patches that promote healing and relieve pain
KR100573206B1 (en) Use of dichlorobenzyl alcohol and preparations containing dichlorobenzyl alcohol for the preparation of agents for the topical treatment of inflammation
WO1987004930A1 (en) Sulphamic science
CN110464821A (en) Draft conserves cream
RU2117473C1 (en) Method of external treatment of foot and smooth skin mycosis
RU2830816C2 (en) Use of phospholipid emulsion containing effective amount of dihydroquercetin, lecithin and glycine for treating chronic and inflammatory oral diseases
RU2790528C1 (en) Method of local treatment of erosive and ulcerative form of flat lichen of the mucous membranes of the mouth
JP2023520867A (en) Treatment Strategies to Address Post-Injury Facial Contractures
RU2137461C1 (en) Composition for treatment of mouth cavity sicknesses
Ghosn Evaluation of sodium stibogluconate in the treatment of cutaneous leishmaniasis in Syria
RU2197950C2 (en) Agent for mouth cavity rinsing
US12115186B1 (en) Topical burn cream
RU2082419C1 (en) Method of treatment of acute respiratory disease
AU2008241370B2 (en) Essential oil of kunzea ambigua and methods of use
RU2020930C1 (en) Oxaplast medicinal preparation for removing mycotically affected nails
CN108904638A (en) A kind of multiduty external application combination drug and application
RU2194495C2 (en) Method for prophylaxis of tick-induced borreliosis
JPH08509994A (en) Methods and compositions for topical treatment of damaged tissue using histamine phosphate as the active ingredient

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): DE GB US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642